Neurology Devices’s aneurysm diagnostic tool is 97.2% predictive in ruling out stroke

US-based has released new trial data that assessed its artificial intelligence (AI) powered neurovascular technology to detect and diagnose…

Gate teams up with Beacon to use EEG biomarkers in Phase II MDD trial

US-based Gate Neurosciences has partnered with Beacon Biosignals to use electroencephalogram (EEG) biomarkers in developing its neuropsychiatry and cognition clinical…


Sign up to the newsletter: In Brief

Your corporate email address *
First name *
Last name *
Company name *
Job title *
Vist our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.